You are currently viewing a new version of our website. To view the old version click .
International Journal of Molecular Sciences
  • Review
  • Open Access

30 January 2019

Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma

,
and
Department of Microbiology and Immunology, Biomedical Sciences, Liver Research Institute and Cancer Research Institute, College of Medicine, Seoul National University, Seoul 03080, Korea
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Endoplasmic Reticulum Stress and Unfolded Protein Response

Abstract

Hepatitis B virus (HBV) infection is a global health problem that causes a wide range of pathological outcomes, including cirrhosis and hepatocellular carcinoma (HCC). Endoplasmic reticulum (ER) stress induction by HBV infection has been implicated in liver carcinogenesis and disease progression with chronic inflammation via enhanced inflammation, oxidative stress-mediated DNA damage, and hepatocyte proliferation. In the natural course of HBV infection, the accumulation of naturally occurring mutations in the HBV genome can generate several mutant types of HBV-encoded proteins, including three different proteins in the S ORF (SHBs, MHBs, and LHBs) and HBcAg in the C ORF, which could contribute to enhanced ER stress in infected hepatocytes mainly via increased ER accumulation of mutant proteins. However, it seems that there may be distinct capacity and pathway in ER stress-induction and distinct resulting clinical outcomes between HBV variants. In addition, the role of HBxAg mutations in ER stress remains unknown. However, it has been reported that HBxAg itself could exert ER stress in infected cells, resulting in HCC generation in chronic HBV patients. To date, review papers regarding ER stress-mediated HBV mutation have been limited into a specific mutation type: preS2 deletion. So, in this review, we will discuss details about various mutation types in all four regions of the HBV genome (preS1, preS2, S, and C) related to ER stress and their distinct ER stress mechanisms and clinical outcomes in terms of mutation types.

1. Introduction

Hepatitis B virus (HBV) infection is responsible for the chronic infection of more than 240 million people worldwide [1,2]. It has been estimated that more than 887,000 people die every year due to serious liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC) [3]. Despite the clear relationship between HBV infection and the development of liver cirrhosis and HCC, the underlying mechanism is still not fully known.
HBV is a member of the Hepadnaviridae family and is a small enveloped DNA virus with a virion diameter of 42 nm containing four overlapping open reading frames (ORFs) named C, S, P, and X. These encode core proteins that form viral capsids; small (SHBs), medium (MHBs), and large (LHBs) envelope proteins that form subviral particles; a polymerase; and the HBx protein, respectively [4]. Of the three proteins encoded by the S ORF, HBsAg is produced at a high rate and can be secreted independently of LHBs and MHBs. Overexpression of LHBs blocks HBsAg secretion [5]. Proper stoichiometry between LHBs and HBsAg envelope proteins is important for the secretion of SHBs and virions [6,7].
Because large amounts of proteins and lipids are synthesized in the liver, hepatocytes have a well-functioning endoplasmic reticulum (ER) with appropriate adaptive capability [8]. However, when ER stress is sustained due to chronic virus infection, it can cause hepatic dysfunctions that can lead to the progression of liver diseases [9]. Many studies have reported that HBV-infected cells showed large amounts of proteins in the ER, which led to ER stress and further contributed to the progression of severe liver diseases such as cirrhosis and HCC [10,11,12]. In most cases, those turned out to be mutant HBV proteins in the cells. To date, details about various mutation types in four HBV ORFs related to ER stress and those distinct mechanisms or specific clinical outcomes have rarely been reviewed. So, in this review, we will discuss details about mutation types in all four regions of the HBV genome (preS1, preS2, S, and C) associated with ER stress and their distinct ER stress-inducing mechanisms and clinical outcomes (Figure 1).
Figure 1. Locations and types of hepatitis B virus (HBV) mutations reported to induce endoplasmic reticulum (ER) stress in previous literature. Mutations in preS1 ([11,13,14,15]), and PreS2 ([11,13,16,17]) deletion in PreS1 and preS2 ([13,15,16,17]), or deletion in both region ([16]) are indicated. Several mutations in S regions are reported ([16,18,19]) including those in "a" determinant ([20]). Mutations in core ([21]) and X region ([22,23,24]) reported to cause ER stress are indicated.

2. ER Stress

The ER is the intracellular organelle in charge of synthesizing, folding, trafficking, and maturing proteins, and it builds a closely connected network with other intracellular organelles such as mitochondria, the Golgi apparatus, endosomes, peroxisomes, and the plasma membrane [25,26,27,28]. Of the ER functions, the proper folding and modification of proteins are the most important roles, and only correctly processed proteins are exported to the Golgi apparatus, with misfolded proteins retained in the ER to be processed further or degraded [29,30].
In a normal situation, the ER maintains a proper balance between the influx of unfolded proteins and its folding capacity [31]. A signal transduction pathway has evolved that adapts to the new folding demands that occur when the balance is disturbed, and the responses are important in ER-rich cells such as lymphocytes and hepatocytes [32]. Viral infection gives the ER an overload of protein by synthesizing a large amount of viral proteins [33,34,35]. HBV is an infrequent virus identified to induce ER stress by established in vivo data [36]. The unfolded or misfolded proteins accumulate and aggregate in the ER, leading to ER stress [37,38]. The unfolded protein response (UPR) is an adaptive system of the ER that relieves ER stress and maintains its homeostasis [25,39,40]. However, overwhelming ER stress and following UPR can cause hepatic inflammation, cell death, tissue damage, and fibrosis, contributing to development of various liver diseases [8,41]. Furthermore, there is growing evidence that ER stress-mediated hepatic inflammation could facilitate the development of liver steatosis and injury [9,42]. Zhang et al. (2011) also reported that tunicamycin, a strong ER stress inducer caused ER stress-mediated liver steatosis and lipogenesis, when injected into mice [43].
Meanwhile, it is now well known that various genotypes of HBV promote development of liver disease with distinct severity. Particularly, genotype C has been repeatedly reported to show worse clinical outcomes. In a meta-analysis research with 43 studies including 14,545 patients, 25% of patients infected with genotype C strain had HCC while only 12% of patients infected with genotype B strain had HCC [44]. PreS/S deletions has been considered as an independent risk factor for HCC and progression of liver diseases, and several studies reported that genotype C more frequently showed preS/S deletions than genotype B [45,46]. Consistently, Somenath Datta et al. (2014) compared serum and tissue samples of LC and HCC patients from India, and they found that genotype C showed higher reactive oxygen species and ER stress level compared with those of genotype B [47]. Sugiyama et al. (2006) also analyzed different HBV genotypes (Aa/A1, Ae/A2, Ba/B2, Bj/B1, C, and D) and those distinct clinical criteria, and they reported that the level of GRP78, a marker of ER stress, was significantly higher in genotype C and Ba than the other geno- or subgenotypes (p < 0.01) [48]. Meanwhile, a recent study performed in Africa region, Bhoola and Kramvis (2016) reported that genotypes A is mainly found in southern Africa with subgenotype A1 predominating. They found that genotype A1 showed higher ER stress with overactivation of ER stress transducers compared with genotypes A2 and D3 via in vitro model experiments [49].
There are three UPR transducers in the ER: PRKR-like endoplasmic reticulum kinase (PERK), inositol-requiring protein 1 (IRE1), and activating transcription factor 6 (ATF6) [50].
PERK is a transmembrane protein located in the ER. In its normal state, PERK is bound with the ER chaperone glucose-regulated protein (GRP78/BiP) [51]. As ER stress occurs, BiP is dissociated from PERK, and PERK changes its oligomerization state from a monomer to an oligomer as it is activated [52]. Once activated, PERK phosphorylates eIF2a, which is associated with the attenuation of translation/protein synthesis. Upon the phosphorylation of eIF2a, activating transcription factor 4 (ATF4) mRNA is translated, and UPR target genes related to apoptosis are induced [53].
IRE1 is a type I transmembrane protein that has dual functions as a kinase and an endoribonuclease [51,54]. Under stress conditions, GRP78 is sequestered to misfolded or unfolded proteins in the ER, and then IRE1 is released. Its endoribonuclease (cytosolic RNAse domain) generates a transcription activator called XBP1 to increase protein folding capacity or lead to the transcriptional induction of genes encoding protein degradation enzymes [55]. Simultaneously, the kinase activity of IRE1 induces apoptotic signaling kinase-1 (ASK-1), Jun-N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), leading to apoptosis [56,57,58].
ATF6 is a type II transmembrane protein in which the N-terminus is in the cytoplasm [59,60]. Similar to PERK and IRE1a, ATF6 is covered by GRP78, but in the presence of ER stress, ATF6 is released and translocated to the Golgi apparatus. After it is cleaved by S1P and S2P in the Golgi, the functional part of ATF6 is sent to the cytosol and then to the nucleus [61]. In the nucleus, ATF6 induces ERAD proteins and chaperones [62].

6. Role of HBxAg in ER Stress

HBx is well known to have an important role in HBV replication and the development of hepatocellular carcinogenesis [82,83,84,85,86,87]. It has been consistently reported that the HBx protein of hepatitis B virus can induce ER stress, but the underlying mechanism of this has not yet been fully elucidated. To date, several HBxAg mutation types including V5M or H94Y, related to disease progression and HCC, have been introduced, but their relationships with ER stress has not been explored.
Several studies have investigated the induction of ER stress-mediated by the HBx protein. Li et al. (2007) [22] identified the role of the HBx protein, which exerts ER stress by inducing the IRE1-XBP1 and ATF6 UPR pathways. Similarly, Cho et al. (2011) [23] investigated the molecular mechanism by which HBx triggers ER stress and its sequencing activation of cyclooxygenase 2 (COX2) expression, an important factor in inflammation. They found that the mitochondrial inner membrane potential was decreased in HBx-exerting cells, which led to metabolic dysfunction in liver cells. Metabolic dysfunction reduced intracellular ATP levels; consequently, the PERK, eIF2α, and ATF4 pathways were activated. The induced ER stress increased COX2 mRNA and protein expression levels. In addition, the induction of COX2 expression was confirmed in hepatocytes and a transgenic mouse model expressing HBx. Western blot data showed that levels of ATF4, peIF2α, and the cleaved form of ATF6 were increased in HBx transiently transfected Huh7 cells and in liver tissues from HBx transgenic mice. Particularly, they found that ATF4 enhanced the expression of COX2 by binding to the COX2 promoter. The ATF4-binding site (5′-TTACGCAATA-3′) was identified, and its binding mechanism was confirmed via ChIP assay. This study indicated that HBx-mediated COX2 induction can contribute to inflammation of the liver via ER stress and mitochondrial dysfunction.
Meanwhile, a recent study by Li et al. (2017) revealed that the HBx protein modulates ER stress response so that it can inhibit apoptosis for its own survival [24]. They found that HBx protein interacted with GRP78 directly, while it was retained in the ER lumen, and its binding to GRP78 relieved ER stress. This interaction led to a reduction in eIF2α phosphorylation and ATF4, CHOP, and Bcl-2 expression. On the other hand, IRE1α, which generates prosurvival signals, was highly activated by HBx, and consequently, the expression of spliced XBP1 was increased. ATF6 was activated at the late time point. Thus, HBx may affect IRE1α and ATF6 of the UPR for cell survival. Meanwhile, PERK, another important UPR transducer, was screened in the presence of HBx, and eIF2α and ATF4 expression was decreased or postponed. Furthermore, HBx-mediated ER stress inhibited apoptosis. The expression levels of CHOP and Bcl-2, an antiapoptotic gene regulated by CHOP, were significantly decreased by HBx. Additionally, HBx inhibited poly (ADP ribose) polymerase 1 (PARP-1), which is an important administrator of DNA repair and apoptosis. Collectively, this study indicated a new mechanism of the HBV-ER stress axis that allows escape of ER stress-induced apoptosis for survival. The HBx-induced UPR signals and their roles in HCC progression are summarized in Table 1.

7. Summary

It seems that HBV variants may have distinct capacity or pathway to induce ER stress and definite resulting clinical outcomes. For example, in HBsAg variants mainly related to OBI, ER stress occurred via increased intracellular accumulation of HBsAg variants. Direct ER accumulation of HBsAg mutants could lead to strong ER stress response beyond maintenance of cell homeostasis by normal UPR, resulting in liver dysfunction via apoptotic cell death. In MHBs and LHBs variants generated by mutations in the preS region, perhaps due to immune pressure or RNA splicing, ER stress occurred via increased intracellular accumulation of MHBs or LHBs variants, or via increased accumulation of HBsAg due to the incorrect ratio of produced LHBs and HBsAg. In contrast to variants of HBsAg, MHBs and LHBs showing defective HBsAg secretion, HBcAg P5T/H/L of M2RR variants generated by host CD4 T cell responses could cause ER stress via ER accumulation of the HBcAg variant, leading to enhanced secretion of HBsAg via S promoter activation. Although there are some discrepancies in ER stress-mediated biological functions according to the type of variants and their ER stress-inducing capacity, they can generally elicit ER stress-mediated biological responses such as ROS production, inflammatory cytokine production, TGF-β secretion, hepatocyte proliferation followed by apoptosis, and enhanced HBsAg secretion (in case of HBcAg variant), all of which are linked to the progression of liver disease. Therefore, prolonged inflammation, liver damage and increased HBsAg secretion in these naturally occurring variants may contribute to the progression of liver disease.

8. Conclusions

In conclusion, in the natural course of HBV infection, the accumulation of naturally occurring mutations in the HBV genome can generate several mutant types of HBV-encoded proteins, including three different proteins in the S ORF (SHBs, MHBs, and LHBs) and HBcAg in the C ORF, which could contribute to enhanced ER stress in infected hepatocytes mainly via increased ER accumulation of mutant proteins. The mutants may have distinct capacity and pathway to induce ER stress and result in definite clinical outcomes. In addition, the role of HBxAg mutations in ER stress remains still unknown. However, it has been reported that HBxAg itself could exert ER stress in infected cells, resulting in HCC generation in chronic HBV patients.

Author Contributions

Writing—Original Draft Preparation, Y.-M.C. and B.-J.K.; Writing—Review and Editing, Y.-M.C., S.-Y.L., and B.-J.K.; Funding Acquisition, B.-J.K.

Funding

This research was supported by the National Research Foundation of Korea (NRF) and funded by the Ministry of Education (Grant No., NRF-2016R1A2B4011847). Yu-Min Choi received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

EREndoplasmic reticulum
HCCHepatocellular carcinoma
UPRUnfolded protein response
PERKProtein kinase RNA (PKR)-like ER kinase
IRE1Inositol-requiring protein 1
ATF6Activating transcription factor 6
ATF4Activating transcription factor 4
GRP78/Bip78-kDa glucose regulated protein/binding immunoglobulin protein
COX-2Cyclooxygenase-2
NFκBNuclear factor-κB
OBIOccult HBV infection

References

  1. WHO. Global Hepatitis Report 2017; World Health Organization: Geneva, Switzerland, 2017. [Google Scholar]
  2. Tang, L.S.Y.; Covert, E.; Wilson, E.; Kottilil, S. Chronic Hepatitis B Infection: A Review. JAMA 2018, 319, 1802–1813. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, H.; Naghavi, M.; Allen, C.; Barber, R.M.; Bhutta, Z.A.; Carter, A.; Casey, D.C.; Charlson, F.J.; Chen, A.Z.; Coates, M.M. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1459–1544. [Google Scholar] [CrossRef]
  4. Ringelhan, M.; Heikenwalder, M.; Protzer, U. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development. Dig. Dis. 2013, 31, 138–151. [Google Scholar] [CrossRef] [PubMed]
  5. Persing, D.H.; Varmus, H.E.; Ganem, D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 1986, 234, 1388–1391. [Google Scholar] [CrossRef] [PubMed]
  6. Chisari, F.V.; Filippi, P.; McLachlan, A.; Milich, D.R.; Riggs, M.; Lee, S.; Palmiter, R.D.; Pinkert, C.A.; Brinster, R.L. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 1986, 60, 880–887. [Google Scholar] [PubMed]
  7. Wu, C.C.; Chen, Y.S.; Cao, L.; Chen, X.W.; Lu, M.J. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World J. Gastroenterol. 2018, 24, 3488–3499. [Google Scholar] [CrossRef] [PubMed]
  8. Kim, S.Y.; Kyaw, Y.Y.; Cheong, J. Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases. World J. Gastroenterol. 2017, 23, 7657–7665. [Google Scholar] [CrossRef]
  9. Malhi, H.; Kaufman, R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 2011, 54, 795–809. [Google Scholar] [CrossRef]
  10. Churin, Y.; Roderfeld, M.; Roeb, E. Hepatitis B virus large surface protein: Function and fame. Hepatobiliary Surg. Nutr. 2015, 4, 1–10. [Google Scholar] [CrossRef]
  11. Montalbano, R.; Honrath, B.; Wissniowski, T.T.; Elxnat, M.; Roth, S.; Ocker, M.; Quint, K.; Churin, Y.; Roederfeld, M.; Schroeder, D.; et al. Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: Involvement of cannabinoid axis in liver cancer cells. Oncotarget 2016, 7, 20312–20323. [Google Scholar] [CrossRef]
  12. Warner, N.; Locarnini, S.; Nguyen, T. Anti-viral medication to prevent HCC development: Where are we now? Cancer Forum 2009, 33, 111–114. [Google Scholar]
  13. Wang, H.C.; Wu, H.C.; Chen, C.F.; Fausto, N.; Lei, H.Y.; Su, I.J. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am. J. Pathol. 2003, 163, 2441–2449. [Google Scholar] [CrossRef]
  14. Xu, Z.; Jensen, G.; Yen, T.S. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J. Virol. 1997, 71, 7387–7392. [Google Scholar] [PubMed]
  15. Bock, C.T.; Tillmann, H.L.; Manns, M.P.; Trautwein, C. The pre-S region determines the intracellular localization and appearance of hepatitis B virus. Hepatology 1999, 30, 517–525. [Google Scholar] [CrossRef] [PubMed]
  16. Pollicino, T.; Amaddeo, G.; Restuccia, A.; Raffa, G.; Alibrandi, A.; Cutroneo, G.; Favaloro, A.; Maimone, S.; Squadrito, G.; Raimondo, G. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology 2012, 56, 434–443. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, H.C.; Huang, W.; Lai, M.D.; Su, I.J. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 2006, 97, 683–688. [Google Scholar] [CrossRef] [PubMed]
  18. Lee, I.K.; Lee, S.A.; Kim, H.; Won, Y.S.; Kim, B.J. Induction of endoplasmic reticulum-derived oxidative stress by an occult infection related S surface antigen variant. World J. Gastroenterol. 2015, 21, 6872–6883. [Google Scholar] [CrossRef]
  19. Chua, P.K.; Wang, R.Y.; Lin, M.H.; Masuda, T.; Suk, F.M.; Shih, C. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J. Virol. 2005, 79, 13483–13496. [Google Scholar] [CrossRef]
  20. Kalinina, T.; Iwanski, A.; Will, H.; Sterneck, M. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 2003, 38, 1274–1281. [Google Scholar] [CrossRef]
  21. Lee, H.; Kim, H.; Lee, S.A.; Won, Y.S.; Kim, H.I.; Inn, K.S.; Kim, B.J. Upregulation of endoplasmic reticulum stress and reactive oxygen species by naturally occurring mutations in hepatitis B virus core antigen. J. Gen. Virol. 2015, 96, 1850–1854. [Google Scholar] [CrossRef]
  22. Li, B.; Gao, B.; Ye, L.; Han, X.; Wang, W.; Kong, L.; Fang, X.; Zeng, Y.; Zheng, H.; Li, S.; et al. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res. 2007, 124, 44–49. [Google Scholar] [CrossRef] [PubMed]
  23. Cho, H.K.; Cheong, K.J.; Kim, H.Y.; Cheong, J. Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. BioChem. J. 2011, 435, 431–439. [Google Scholar] [CrossRef] [PubMed]
  24. Li, J.; He, J.; Fu, Y.; Hu, X.; Sun, L.Q.; Huang, Y.; Fan, X. Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response. Oncotarget 2017, 8, 96027–96034. [Google Scholar] [CrossRef] [PubMed]
  25. Guzel, E.; Arlier, S.; Guzeloglu-Kayisli, O.; Tabak, M.S.; Ekiz, T.; Semerci, N.; Larsen, K.; Schatz, F.; Lockwood, C.J.; Kayisli, U.A. Endoplasmic Reticulum Stress and Homeostasis in Reproductive Physiology and Pathology. Int. J. Mol. Sci. 2017, 18, 792. [Google Scholar] [CrossRef] [PubMed]
  26. Schwarz, D.S.; Blower, M.D. The endoplasmic reticulum: Structure, function and response to cellular signaling. Cell. Mol. Life Sci. 2016, 73, 79–94. [Google Scholar] [CrossRef] [PubMed]
  27. Khodaee, N.; Ghasemi, M.; Saghiri, R.; Eliassi, A. Endoplasmic reticulum membrane potassium channel dysfunction in high fat diet induced stress in rat hepatocytes. EXCLI J. 2014, 13, 1075–1087. [Google Scholar] [PubMed]
  28. Lee, C.; Ferguson, M.; Chen, L.B. Construction of the endoplasmic reticulum. J. Cell Biol. 1989, 109, 2045–2055. [Google Scholar] [CrossRef] [PubMed]
  29. Gomez-Navarro, N.; Miller, E. Protein sorting at the ER–Golgi interface. J. Cell Biol. 2016, 215, 769–778. [Google Scholar] [CrossRef] [PubMed]
  30. Koenig, P.A.; Ploegh, H.L. Protein quality control in the endoplasmic reticulum. F1000Prime Rep. 2014, 6, 49. [Google Scholar] [CrossRef]
  31. Khan, M.M.; Yang, W.L.; Wang, P. Endoplasmic Reticulum Stress in Sepsis. Shock 2015, 44, 294–304. [Google Scholar] [CrossRef]
  32. Dara, L.; Ji, C.; Kaplowitz, N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 2011, 53, 1752–1763. [Google Scholar] [CrossRef]
  33. Zhang, L.; Wang, A. Virus-induced ER stress and the unfolded protein response. Front. Plant. Sci. 2012, 3, 293. [Google Scholar] [CrossRef]
  34. Chan, S.W. The unfolded protein response in virus infections. Front. MicroBiol. 2014, 5, 518. [Google Scholar] [CrossRef]
  35. Li, S.; Kong, L.; Yu, X. The expanding roles of endoplasmic reticulum stress in virus replication and pathogenesis. Crit. Rev. MicroBiol. 2015, 41, 150–164. [Google Scholar] [CrossRef] [PubMed]
  36. Lazar, C.; Uta, M.; Branza-Nichita, N. Modulation of the unfolded protein response by the human hepatitis B virus. Front. MicroBiol. 2014, 5, 433. [Google Scholar] [CrossRef]
  37. Chemin, I.; Zoulim, F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett. 2009, 286, 52–59. [Google Scholar] [CrossRef] [PubMed]
  38. Haeri, M.; Knox, B.E. Endoplasmic Reticulum Stress and Unfolded Protein Response Pathways: Potential for Treating Age-related Retinal Degeneration. J. Ophthalmic Vis. Res. 2012, 7, 45–59. [Google Scholar] [PubMed]
  39. Zhu, G.; Lee, A.S. Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis. J. Cell. Physiol. 2015, 230, 1413–1420. [Google Scholar] [CrossRef]
  40. Bettigole, S.E.; Glimcher, L.H. Endoplasmic reticulum stress in immunity. Annu. Rev. Immunol. 2015, 33, 107–138. [Google Scholar] [CrossRef]
  41. Guo, B.; Li, Z. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Front. Genet. 2014, 5, 242. [Google Scholar] [CrossRef]
  42. Cnop, M.; Foufelle, F.; Velloso, L.A. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 2012, 18, 59–68. [Google Scholar] [CrossRef] [PubMed]
  43. Zhang, K.; Wang, S.; Malhotra, J.; Hassler, J.R.; Back, S.H.; Wang, G.; Chang, L.; Xu, W.; Miao, H.; Leonardi, R. The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis. EMBO J. 2011, 30, 1357–1375. [Google Scholar] [CrossRef] [PubMed]
  44. Liu, S.; Zhang, H.; Gu, C.; Yin, J.; He, Y.; Xie, J.; Cao, G. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis. J. Natl. Cancer Inst. 2009, 101, 1066–1082. [Google Scholar] [CrossRef] [PubMed]
  45. Lin, C.L.; Liu, C.H.; Chen, W.; Huang, W.L.; Chen, P.J.; Lai, M.Y.; Chen, D.S.; Kao, J.H. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2007, 22, 1098–1103. [Google Scholar] [CrossRef]
  46. Lin, C.L.; Kao, J.H. Clinical implications of hepatitis B virus variants. J. Med. Assoc. 2010, 109, 321–325. [Google Scholar] [CrossRef]
  47. Datta, S.; Roychoudhury, S.; Ghosh, A.; Dasgupta, D.; Ghosh, A.; Chakraborty, B.C.; Ray, S.; Gupta, S.; Santra, A.K.; Datta, S.; et al. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients. PLoS ONE 2014, 9, e102573. [Google Scholar] [CrossRef] [PubMed]
  48. Sugiyama, M.; Tanaka, Y.; Kato, T.; Orito, E.; Ito, K.; Acharya, S.K.; Gish, R.G.; Kramvis, A.; Shimada, T.; Izumi, N.; et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 2006, 44, 915–924. [Google Scholar] [CrossRef] [PubMed]
  49. Bhoola, N.H.; Kramvis, A. Hepatitis B e Antigen Expression by Hepatitis B Virus Subgenotype A1 Relative to Subgenotypes A2 and D3 in Cultured Hepatocellular Carcinoma (Huh7) Cells. Intervirology 2016, 59, 48–59. [Google Scholar] [CrossRef] [PubMed]
  50. Gardner, B.M.; Pincus, D.; Gotthardt, K.; Gallagher, C.M.; Walter, P. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb. Perspect. Biol. 2013, 5, a013169. [Google Scholar] [CrossRef]
  51. Liu, Z.; Lv, Y.; Zhao, N.; Guan, G.; Wang, J. Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate. Cell Death Dis. 2015, 6, e1822. [Google Scholar] [CrossRef]
  52. Kimata, Y.; Shimizu, Y.; Oikawa, D.; Kimata, Y.; Kohno, K. A role of BiP as an adjustor for the endoplasmic reticulum stress-sensing protein Ire1. J. Cell Biol. 2004, 167, 445–456. [Google Scholar] [CrossRef] [PubMed]
  53. Lumley, E.C.; Osborn, A.R.; Scott, J.E.; Scholl, A.G.; Mercado, V.; McMahan, Y.T.; Coffman, Z.G.; Brewster, J.L. Moderate endoplasmic reticulum stress activates a PERK and p38-dependent apoptosis. Cell Stress Chaperones 2017, 22, 43–54. [Google Scholar] [CrossRef] [PubMed]
  54. Liu, C.Y.; Wong, H.N.; Schauerte, J.A.; Kaufman, R.J. The protein kinase/endoribonuclease IRE1α that signals the unfolded protein response has a luminal N-terminal ligand-independent dimerization domain. J. Biol. Chem. 2002, 277, 18346–18356. [Google Scholar] [CrossRef] [PubMed]
  55. Yoshida, H.; Matsui, T.; Yamamoto, A.; Okada, T.; Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001, 107, 881–891. [Google Scholar] [CrossRef]
  56. Sano, R.; Reed, J.C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 2013, 1833, 3460–3470. [Google Scholar] [CrossRef] [PubMed]
  57. Urano, F.; Wang, X.Z.; Bertolotti, A.; Zhang, Y.H.; Chung, P.; Harding, H.P.; Ron, D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287, 664–666. [Google Scholar] [CrossRef] [PubMed]
  58. Xue, L.X.; Liu, H.Y.; Cui, Y.; Dong, Y.; Wang, J.Q.; Ji, Q.Y.; He, J.T.; Yao, M.; Wang, Y.Y.; Shao, Y.K.; et al. Neuroprotective effects of Activin A on endoplasmic reticulum stress-mediated apoptotic and autophagic PC12 cell death. Neural Regen. Res. 2017, 12, 779–786. [Google Scholar] [CrossRef] [PubMed]
  59. Horimoto, S.; Ninagawa, S.; Okada, T.; Koba, H.; Sugimoto, T.; Kamiya, Y.; Kato, K.; Takeda, S.; Mori, K. The unfolded protein response transducer ATF6 represents a novel transmembrane-type endoplasmic reticulum-associated degradation substrate requiring both mannose trimming and SEL1L protein. J. Biol. Chem. 2013, 288, 31517–31527. [Google Scholar] [CrossRef] [PubMed]
  60. Haze, K.; Okada, T.; Yoshida, H.; Yanagi, H.; Yura, T.; Negishi, M.; Mori, K. Identification of the G13 (cAMP-response-element-binding protein-related protein) gene product related to activating transcription factor 6 as a transcriptional activator of the mammalian unfolded protein response. Biochem. J. 2001, 355, 19–28. [Google Scholar] [CrossRef] [PubMed]
  61. Nadanaka, S.; Yoshida, H.; Kano, F.; Murata, M.; Mori, K. Activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum. Mol. Biol. Cell 2004, 15, 2537–2548. [Google Scholar] [CrossRef]
  62. Schuck, S.; Prinz, W.A.; Thorn, K.S.; Voss, C.; Walter, P. Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response. J. Cell Biol. 2009, 187, 525–536. [Google Scholar] [CrossRef]
  63. Su, I.J.; Wang, L.H.; Hsieh, W.C.; Wu, H.C.; Teng, C.F.; Tsai, H.W.; Huang, W. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis. J. Biomed. Sci. 2014, 21, 98. [Google Scholar] [CrossRef] [PubMed]
  64. Ou, J.H.; Rutter, W.J. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J. Virol. 1987, 61, 782–786. [Google Scholar] [PubMed]
  65. Chisari, F.V.; Filippi, P.; Buras, J.; McLachlan, A.; Popper, H.; Pinkert, C.A.; Palmiter, R.D.; Brinster, R.L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA 1987, 84, 6909–6913. [Google Scholar] [CrossRef]
  66. Hildt, E.; Munz, B.; Saher, G.; Reifenberg, K.; Hofschneider, P.H. The PreS2 activator MHBst of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J. 2002, 21, 525–535. [Google Scholar] [CrossRef] [PubMed]
  67. Yeung, P.; Wong, D.K.; Lai, C.L.; Fung, J.; Seto, W.K.; Yuen, M.F. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J. Infect. Dis. 2011, 203, 646–654. [Google Scholar] [CrossRef] [PubMed]
  68. Kao, J.H.; Liu, C.J.; Jow, G.M.; Chen, P.J.; Chen, D.S.; Chen, B.F. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. Liver Int. 2012, 32, 1373–1381. [Google Scholar] [CrossRef] [PubMed]
  69. Zhang, Z.H.; Wu, C.C.; Chen, X.W.; Li, X.; Li, J.; Lu, M.J. Genetic variation of hepatitis B virus and its significance for pathogenesis. World J. Gastroenterol. 2016, 22, 126–144. [Google Scholar] [CrossRef]
  70. Su, I.J.; Wang, H.C.; Wu, H.C.; Huang, W.Y. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2008, 23, 1169–1174. [Google Scholar] [CrossRef]
  71. Lin, Y.M.; Chen, B.F. A putative hepatitis B virus splice variant associated with chronic hepatitis and liver cirrhosis. Virology 2017, 510, 224–233. [Google Scholar] [CrossRef]
  72. Abe, K.; Thung, S.N.; Wu, H.C.; Tran, T.T.; Le Hoang, P.; Truong, K.D.; Inui, A.; Jang, J.J.; Su, I.J. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009, 100, 2249–2254. [Google Scholar] [CrossRef]
  73. Huang, H.P.; Hsu, H.Y.; Chen, C.L.; Ni, Y.H.; Wang, H.Y.; Tsuei, D.J.; Chiang, C.L.; Tsai, Y.C.; Chen, H.L.; Chang, M.H. Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children. Pediatr. Res. 2010, 67, 90–94. [Google Scholar] [CrossRef] [PubMed]
  74. Chisari, F.V.; Ferrari, C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13, 29–60. [Google Scholar] [CrossRef]
  75. Cooreman, M.P.; Leroux-Roels, G.; Paulij, W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 2001, 8, 237–247. [Google Scholar] [CrossRef] [PubMed]
  76. Khan, N.; Guarnieri, M.; Ahn, S.H.; Li, J.; Zhou, Y.; Bang, G.; Kim, K.H.; Wands, J.R.; Tong, S. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J. Virol. 2004, 78, 3262–3270. [Google Scholar] [CrossRef] [PubMed]
  77. Kim, H.; Lee, S.A.; Won, Y.S.; Lee, H.; Kim, B.J. Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity. World J. Gastroenterol. 2015, 21, 1794–1803. [Google Scholar] [CrossRef] [PubMed]
  78. Cao, S.S.; Kaufman, R.J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 2014, 21, 396–413. [Google Scholar] [CrossRef] [PubMed]
  79. Pollicino, T.; Saitta, C. Occult hepatitis B virus and hepatocellular carcinoma. World J. Gastroenterol. 2014, 20, 5951–5961. [Google Scholar] [CrossRef] [PubMed]
  80. Kim, H.; Lee, S.A.; Do, S.Y.; Kim, B.J. Precore/core region mutations of hepatitis B virus related to clinical severity. World J. Gastroenterol. 2016, 22, 4287–4296. [Google Scholar] [CrossRef]
  81. Malik, A.; Singhal, D.K.; Albanyan, A.; Husain, S.A.; Kar, P. Hepatitis B virus gene mutations in liver diseases: A report from New Delhi. PLoS ONE 2012, 7, e39028. [Google Scholar] [CrossRef]
  82. Li, C.H.; Xu, F.; Chow, S.; Feng, L.; Yin, D.; Ng, T.B.; Chen, Y. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur. J. Cancer 2014, 50, 2560–2569. [Google Scholar] [CrossRef] [PubMed]
  83. Ali, A.; Abdel-Hafiz, H.; Suhail, M.; Al-Mars, A.; Zakaria, M.K.; Fatima, K.; Ahmad, S.; Azhar, E.; Chaudhary, A.; Qadri, I. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J. Gastroenterol. 2014, 20, 10238–10248. [Google Scholar] [CrossRef] [PubMed]
  84. Hwang, G.Y.; Lin, C.Y.; Huang, L.M.; Wang, Y.H.; Wang, J.C.; Hsu, C.T.; Yang, S.S.; Wu, C.C. Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J. Clin. Microbiol. 2003, 41, 5598–5603. [Google Scholar] [CrossRef] [PubMed]
  85. Wang, D.; Cai, H.; Yu, A.B.; Yu, L. Identification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China. Int. J. Clin. Exp. Pathol. 2014, 7, 5988–5996. [Google Scholar] [PubMed]
  86. Zhang, Y.; Liu, H.; Yi, R.; Yan, T.; He, Y.; Zhao, Y.; Liu, J. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression. J. Exp. Clin. Cancer Res. 2016, 35, 87. [Google Scholar] [CrossRef] [PubMed]
  87. Pollicino, T.; Saitta, C.; Raimondo, G. Hepatocellular carcinoma: The poInt. of view of the hepatitis B virus. Carcinogenesis 2011, 32, 1122–1132. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.